Hints and tips:
...J&J last week agreed the sale of its ortho-clinical diagnostics unit, which includes blood testing equipment, to Carlyle, the private equity group, for $4.15bn as part of efforts to narrow the group’s focus...
...In 2011 the US Food and Drug Administration said it had imposed a “consent decree” on J&J’s McNeil-PPC subsidiary and two of its offices to force the company to improve manufacturing standards....
...one of several US legal actions related to marketing of its products, the report describes a “doctor for a day” programme used until 2003 that was developed by the sales force and “not …management” of Ortho-McNeil...
...Pfizer’s decision to close its research laboratory at Sandwich is widely seen as a setback for recovery in Britain, a country that played a leading role in the development of the modern research-based pharmaceutical...
...The terms of the agreement between J&J’s subsidiary Centocor Ortho Biotech and Schering-Plough allow arbitration within 30 days of a change of ownership....
...Isis Pharmaceuticals rose 4.2 per cent to $13.30 after it announced a collaboration with Ortho-McNeil, a unit of Johnson & Johnson , up 1 per cent at $63.11, for the treatment of various medical disorders...
...The retailer said it would start selling a monthly supply of generic versions of Ortho Cyclen and Ortho Tri Cyclen birth control drugs for $9, compared to current prices of $24 to $30, introducing a second...
...Thus Texas Instruments got out of home computers and defence electronics to focus on semiconductors; Westinghouse evolved into CBS, the media group; Imperial Chemical Industries spun out its pharmaceuticals...
International Edition